|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 8/09/16 American Renal Assocs Holdin… Inc 10-Q 6/30/16 58:5.7M |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 779K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 25K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 24K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 21K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 20K
12: R1 Document and Entity Information HTML 38K
13: R2 Consolidated Balance Sheets HTML 109K
14: R3 Consolidated Balance Sheets (Parenthetical) HTML 42K
15: R4 Consolidated Statements of Operations HTML 83K
16: R5 Consolidated Statements of Comprehensive Income HTML 32K
(Loss)
17: R6 Consolidated Statements of Changes in Equity HTML 85K
18: R7 Consolidated Statements of Changes in Equity HTML 21K
(Parenthetical)
19: R8 Consolidated Statements of Cash Flows HTML 134K
20: R9 Basis of Presentation and Organization HTML 42K
21: R10 Accounts Receivable HTML 24K
22: R11 Acquisitions HTML 35K
23: R12 Fair Value Measurements HTML 121K
24: R13 Accrued Expenses and Other Current Liabilities HTML 45K
25: R14 Variable Interest Entities HTML 28K
26: R15 Noncontrolling Interests Subject to Put Provisions HTML 23K
27: R16 Debt HTML 75K
28: R17 Income Taxes HTML 23K
29: R18 Stock-Based Compensation HTML 73K
30: R19 Earnings Per Share HTML 103K
31: R20 Related Party Transactions HTML 35K
32: R21 Commitments and Contingencies HTML 29K
33: R22 Subsequent Events HTML 19K
34: R23 Basis of Presentation and Organization (Policies) HTML 44K
35: R24 Acquisitions (Tables) HTML 27K
36: R25 Fair Value Measurements (Tables) HTML 114K
37: R26 Accrued Expenses and Other Current Liabilities HTML 46K
(Tables)
38: R27 Debt (Tables) HTML 62K
39: R28 Stock-Based Compensation (Tables) HTML 63K
40: R29 Earnings Per Share (Tables) HTML 100K
41: R30 Basis of Presentation and Organization (Details) HTML 74K
42: R31 Accounts Receivable (Details) HTML 27K
43: R32 Acquisitions (Details) HTML 31K
44: R33 Fair Value Measurements (Details) HTML 70K
45: R34 Accrued Expenses and Other Current Liabilities HTML 35K
(Details)
46: R35 Variable Interest Entities Loans (Details) HTML 24K
47: R36 Noncontrolling Interests Subject to Put Provisions HTML 22K
(Details)
48: R37 Debt (Details) HTML 59K
49: R38 Debt - Credit And Interest Rate Swap Agreements HTML 89K
(Details)
50: R39 Income Taxes (Details) HTML 23K
51: R40 Stock-Based Compensation (Details) HTML 86K
52: R41 Earnings Per Share (Details) HTML 54K
53: R42 Related Party Transactions (Details) HTML 66K
54: R43 Commitments and Contingencies (Details) HTML 26K
55: R44 Subsequent Events (Details) HTML 19K
57: XML IDEA XML File -- Filing Summary XML 98K
56: EXCEL IDEA Workbook of Financial Reports XLSX 59K
6: EX-101.INS XBRL Instance -- c068-20160630 XML 1.15M
8: EX-101.CAL XBRL Calculations -- c068-20160630_cal XML 150K
9: EX-101.DEF XBRL Definitions -- c068-20160630_def XML 385K
10: EX-101.LAB XBRL Labels -- c068-20160630_lab XML 1.04M
11: EX-101.PRE XBRL Presentations -- c068-20160630_pre XML 715K
7: EX-101.SCH XBRL Schema -- c068-20160630 XSD 112K
58: ZIP XBRL Zipped Folder -- 0001498068-16-000011-xbrl Zip 119K
| ara_Ex31-1 |
SECTION 302 CERTIFICATION
I, Joseph A. Carlucci, certify that:
|
1. |
I have reviewed this Quarterly Report on Form 10-Q for the quarter ended June 30, 2016 of American Renal Associates Holdings, Inc. (the “registrant”); |
|
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
|
4. |
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)) and 15d-15(e)) for the registrant and have: |
|
(a) |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
(b) |
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
(c) |
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
|
5. |
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
|
(a) |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
|
(b) |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
|
|
|
Chief Executive Officer |
Date: August 9, 2016